Arjuna Capital Novartis Ag Transaction History

Arjuna Capital

$363 Million
Q4 2024

A detailed history of Arjuna Capital transactions in Novartis Ag stock. As of the latest transaction made, Arjuna Capital holds 13,106 shares of NVS stock, worth $1.42 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

13,106

Previous 13,304 1.49%

Holding current value

$1.42 Million

Previous $1.53 Million 16.67%

% of portfolio

0.35%

Previous 0.41%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$96.78 - $117.18 $19,162 - $23,201	-198 Reduced 1.49%	13,106 $1.28 Million
Q3 2024 Nov 05, 2024	BUY	$106.13 - $120.89 $7,322 - $8,341	69 Added 0.52%	13,304 $1.53 Million
Q2 2024 Jul 29, 2024	BUY	$92.57 - $107.37 $2,869 - $3,328	31 Added 0.23%	13,235 $1.41 Million
Q1 2024 May 13, 2024	SELL	$95.27 - $108.47 $945,745 - $1.08 Million	-9,927 Reduced 42.92%	13,204 $1.28 Million
Q4 2023 Feb 08, 2024	BUY	$92.27 - $101.54 $98,544 - $108,444	1,068 Added 4.84%	23,131 $2.34 Million
Q3 2023 Nov 09, 2023	BUY	$94.73 - $105.13 $2.09 Million - $2.32 Million	22,063 New	22,063 $2.25 Million
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $779,625 - $862,087	-9,782 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$81.78 - $95.14 $13,902 - $16,173	-170 Reduced 1.71%	9,782 $800,000
Q2 2021 Aug 11, 2021	BUY	$85.24 - $94.15 $18,923 - $20,901	222 Added 2.28%	9,952 $908,000
Q1 2021 May 11, 2021	BUY	$83.5 - $98.47 $36,489 - $43,031	437 Added 4.7%	9,730 $832,000
Q4 2020 Feb 09, 2021	BUY	$78.07 - $94.43 $37,239 - $45,043	477 Added 5.41%	9,293 $878,000
Q3 2020 Nov 05, 2020	BUY	$82.14 - $91.0 $11,663 - $12,922	142 Added 1.64%	8,816 $767,000
Q2 2020 Aug 13, 2020	BUY	$80.93 - $91.1 $15,133 - $17,035	187 Added 2.2%	8,674 $758,000
Q1 2020 May 11, 2020	BUY	$70.67 - $99.01 $599,776 - $840,297	8,487 New	8,487 $700,000
Q2 2019 Aug 08, 2019	SELL	$75.4 - $92.8 $1.29 Million - $1.59 Million	-17,150 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $20,863 - $23,863	277 Added 1.64%	17,150 $1.65 Million
Q4 2018 Jan 31, 2019	SELL	$73.66 - $82.02 $24,528 - $27,312	-333 Reduced 1.94%	16,873 $1.45 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $11,647 - $13,472	-174 Reduced 1.0%	17,206 $1.48 Million
Q2 2018 Aug 01, 2018	SELL	$64.91 - $73.36 $90,484 - $102,263	-1,394 Reduced 7.43%	17,380 $1.31 Million
Q1 2018 Apr 24, 2018	BUY	$70.39 - $84.15 $18,512 - $22,131	263 Added 1.42%	18,774 $1.52 Million
Q4 2017 Feb 09, 2018	BUY	$72.33 - $77.64 $1.34 Million - $1.44 Million	18,511	18,511 $1.55 Million

Others Institutions Holding NVS

# of Institutions

1,479

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $234B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arjuna Capital, based on Form 13F filings with the SEC.

News

Stay updated on Arjuna Capital with notifications on news.

Account